We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Walmart, UnitedHealth, Wells Fargo, XMax and Interlink Electronics
Read MoreHide Full Article
For Immediate Release
Chicago, IL – September 15, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Walmart Inc. (WMT - Free Report) , UnitedHealth Group Inc. (UNH - Free Report) , Wells Fargo & Co. (WFC - Free Report) , XMax Inc. (XMAX - Free Report) and Interlink Electronics, Inc. (LINK - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Walmart, United Health and Wells Fargo
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc., UnitedHealth Group Inc. and Wells Fargo & Co., as well as two micro-cap stocks XMax Inc. and Interlink Electronics, Inc.. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Walmart's shares have outperformed the Zacks Retail - Supermarkets industry over the past year (+4.2% vs. +3.1%). The company's scale, value positioning and integrated omnichannel model provide a strong foundation for sustained growth. Traffic and market-share gains remain healthy, while e-commerce, marketplace, advertising and membership are expanding the revenue mix and improving digital economics.
International operations and Sam's Club add further diversification. However, elevated operating costs, pharmacy-related sales pressure and heavy capital spending can limit earnings leverage and free-cash-flow conversion.
Continued price reinvestment supports customer loyalty and share gains but may restrain margin expansion, while currency swings can add volatility. While Walmart's fundamentals remain resilient, stronger returns will depend on disciplined execution, productivity gains and successful monetization of its expanding retail ecosystem.
Shares of UnitedHealth have gained +11.1% over the past year against the Zacks Medical - HMOs industry's gain of +14.9%. The company's improving medical-cost trends helped strengthen its performance. Optum remains a key growth driver through its pharmacy services, technology integration, and government solutions.
A strong market position, ongoing expansion initiatives, and rising healthcare demand support long-term growth. Fee-based commercial membership remained on a growth path despite elevated medical costs. The higher-than-expected 2027 Medicare Advantage payment rate increase provides additional support for growth.
The company raised its 2026 adjusted EPS outlook to $19.50-$20.00. Robust cash generation supports shareholder returns and financial flexibility, with operating cash flow up 57.9% YoY in the first half of 2026. The Zacks Outperform recommendation reflects UNH's attractive growth prospects and meaningful upside potential from current levels.
Wells Fargo's shares have gained +13.3% over the past year against the Zacks Financial - Investment Bank industry's gain of +22.8%. The company's earnings beat estimates in three of the trailing four quarters. The removal of the asset cap is expected to enable the company to further expand deposits, grow its loan portfolio and scale its fee-based businesses.
The planned launch of tokenized deposits could strengthen its transaction-banking capabilities. A strong capital and liquidity position supports shareholder returns, including the latest 11% dividend hike post-clearing the 2026 Fed stress test. Investments in technology, along with continued branch optimization, are likely to aid its long-term growth.
However, net interest income (NII) growth will likely remain under pressure in the near term, weighing on revenues. Further, its mortgage banking income remains weak amid ongoing volatility in mortgage rates.
XMax's shares have outperformed the Zacks Furniture industry over the past year (+67.3% vs. -23.7%). This microcap company with a market capitalization of $551.67 million has transitioned toward AI, creating a new avenue for growth as commercialization of its API platform begins, supported by stronger liquidity and its furniture business. Private technology investments may offer long-term value creation.
However, the investment case remains execution dependent. The core furniture business continues to face demand pressure, while AI operations are still at an early stage of profitability and require effective cost control and customer scaling.
Negative operating cash flow, weak receivables conversion, customer and supplier concentration, potential share dilution and dependence on unrealized investment gains add uncertainty. The current valuation suggests investors are assigning significant value to the AI strategy and future growth, leaving limited room for execution shortfalls or slower-than-expected commercialization.
Shares of Interlink Electronics have gained +50.5% over the year-to-date period against the Zacks Electronics - Miscellaneous Services industry's gain of +85.1%. This microcap company with a market capitalization of $92 million saw its first-half 2026 gross profit rise 20.9%, gross margin expand to 44.0% from 40.9%, and its net loss narrow sharply to $0.1 million from $0.7 million.
Medical and standard-product revenues grew 30.5% and 34.8%, respectively, broadening the revenue base, while acquisitions, cross-selling, long-lived design wins and exposure to expanding sensing markets provide additional growth avenues. Acquired businesses have also shown meaningful margin improvement, supporting scalability.
However, customer concentration remains high, industrial revenue fell 18.8% in the first half of 2026, and Q2 gross margin slipped slightly year over year amid an unfavorable product mix. Rising SG&A costs, lower R&D spending and regulatory and supply-chain exposure could also limit operating leverage. Valuation is mixed, with EV/sales below industry and sector levels but price/book above key benchmarks.
Free: Instant Access to Zacks' Market-Crushing Strategies
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
View the Zacks #1 Rank List
Image: Bigstock
The Zacks Analyst Blog Highlights Walmart, UnitedHealth, Wells Fargo, XMax and Interlink Electronics
For Immediate Release
Chicago, IL – September 15, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Walmart Inc. (WMT - Free Report) , UnitedHealth Group Inc. (UNH - Free Report) , Wells Fargo & Co. (WFC - Free Report) , XMax Inc. (XMAX - Free Report) and Interlink Electronics, Inc. (LINK - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Walmart, United Health and Wells Fargo
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc., UnitedHealth Group Inc. and Wells Fargo & Co., as well as two micro-cap stocks XMax Inc. and Interlink Electronics, Inc.. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Today's Featured Research Reports
Walmart's shares have outperformed the Zacks Retail - Supermarkets industry over the past year (+4.2% vs. +3.1%). The company's scale, value positioning and integrated omnichannel model provide a strong foundation for sustained growth. Traffic and market-share gains remain healthy, while e-commerce, marketplace, advertising and membership are expanding the revenue mix and improving digital economics.
International operations and Sam's Club add further diversification. However, elevated operating costs, pharmacy-related sales pressure and heavy capital spending can limit earnings leverage and free-cash-flow conversion.
Continued price reinvestment supports customer loyalty and share gains but may restrain margin expansion, while currency swings can add volatility. While Walmart's fundamentals remain resilient, stronger returns will depend on disciplined execution, productivity gains and successful monetization of its expanding retail ecosystem.
(You can read the full research report on Walmart here >>>)
Shares of UnitedHealth have gained +11.1% over the past year against the Zacks Medical - HMOs industry's gain of +14.9%. The company's improving medical-cost trends helped strengthen its performance. Optum remains a key growth driver through its pharmacy services, technology integration, and government solutions.
A strong market position, ongoing expansion initiatives, and rising healthcare demand support long-term growth. Fee-based commercial membership remained on a growth path despite elevated medical costs. The higher-than-expected 2027 Medicare Advantage payment rate increase provides additional support for growth.
The company raised its 2026 adjusted EPS outlook to $19.50-$20.00. Robust cash generation supports shareholder returns and financial flexibility, with operating cash flow up 57.9% YoY in the first half of 2026. The Zacks Outperform recommendation reflects UNH's attractive growth prospects and meaningful upside potential from current levels.
(You can read the full research report on UnitedHealth here >>>)
Wells Fargo's shares have gained +13.3% over the past year against the Zacks Financial - Investment Bank industry's gain of +22.8%. The company's earnings beat estimates in three of the trailing four quarters. The removal of the asset cap is expected to enable the company to further expand deposits, grow its loan portfolio and scale its fee-based businesses.
The planned launch of tokenized deposits could strengthen its transaction-banking capabilities. A strong capital and liquidity position supports shareholder returns, including the latest 11% dividend hike post-clearing the 2026 Fed stress test. Investments in technology, along with continued branch optimization, are likely to aid its long-term growth.
However, net interest income (NII) growth will likely remain under pressure in the near term, weighing on revenues. Further, its mortgage banking income remains weak amid ongoing volatility in mortgage rates.
(You can read the full research report on Wells Fargo here >>>)
XMax's shares have outperformed the Zacks Furniture industry over the past year (+67.3% vs. -23.7%). This microcap company with a market capitalization of $551.67 million has transitioned toward AI, creating a new avenue for growth as commercialization of its API platform begins, supported by stronger liquidity and its furniture business. Private technology investments may offer long-term value creation.
However, the investment case remains execution dependent. The core furniture business continues to face demand pressure, while AI operations are still at an early stage of profitability and require effective cost control and customer scaling.
Negative operating cash flow, weak receivables conversion, customer and supplier concentration, potential share dilution and dependence on unrealized investment gains add uncertainty. The current valuation suggests investors are assigning significant value to the AI strategy and future growth, leaving limited room for execution shortfalls or slower-than-expected commercialization.
(You can read the full research report on XMax here >>>)
Shares of Interlink Electronics have gained +50.5% over the year-to-date period against the Zacks Electronics - Miscellaneous Services industry's gain of +85.1%. This microcap company with a market capitalization of $92 million saw its first-half 2026 gross profit rise 20.9%, gross margin expand to 44.0% from 40.9%, and its net loss narrow sharply to $0.1 million from $0.7 million.
Medical and standard-product revenues grew 30.5% and 34.8%, respectively, broadening the revenue base, while acquisitions, cross-selling, long-lived design wins and exposure to expanding sensing markets provide additional growth avenues. Acquired businesses have also shown meaningful margin improvement, supporting scalability.
However, customer concentration remains high, industrial revenue fell 18.8% in the first half of 2026, and Q2 gross margin slipped slightly year over year amid an unfavorable product mix. Rising SG&A costs, lower R&D spending and regulatory and supply-chain exposure could also limit operating leverage. Valuation is mixed, with EV/sales below industry and sector levels but price/book above key benchmarks.
(You can read the full research report on Interlink Electronics here >>>)
Free: Instant Access to Zacks' Market-Crushing Strategies
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached.
Get all the details here >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.